KRTAP5-11
gene geneOn this page
Also known as KRTAP5.11KRTAP5-6
Summary
KRTAP5-11 (keratin associated protein 5-11, HGNC:23606) is a protein-coding gene on chromosome 11q13.4, encoding Keratin-associated protein 5-11 (Q6L8G4). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated protein (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linki….
Predicted to be located in cytosol.
Source: NCBI Gene 440051 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 51 total
- MANE Select transcript:
NM_001005405
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23606 |
| Approved symbol | KRTAP5-11 |
| Name | keratin associated protein 5-11 |
| Location | 11q13.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KRTAP5.11, KRTAP5-6 |
| Ensembl gene | ENSG00000204571 |
| Ensembl biotype | protein_coding |
| Entrez | 440051 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000398530, ENST00000526239
RefSeq mRNA: 1 — MANE Select: NM_001005405
NM_001005405
CCDS: CCDS41685
Canonical transcript exons
ENST00000398530 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001533486 | 71581855 | 71582875 |
Expression profiles
Bgee: expression breadth broad, 41 present calls, max score 53.24.
Top tissues by expression
109 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| nucleus accumbens | UBERON:0001882 | 53.24 | gold quality |
| caudate nucleus | UBERON:0001873 | 51.12 | gold quality |
| primary visual cortex | UBERON:0002436 | 50.08 | silver quality |
| right hemisphere of cerebellum | UBERON:0014890 | 46.96 | gold quality |
| cerebellum | UBERON:0002037 | 46.47 | silver quality |
| cerebellar cortex | UBERON:0002129 | 46.36 | silver quality |
| cerebellar hemisphere | UBERON:0002245 | 46.33 | silver quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 44.90 | gold quality |
| putamen | UBERON:0001874 | 44.66 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 44.35 | gold quality |
| colonic epithelium | UBERON:0000397 | 44.09 | gold quality |
| right frontal lobe | UBERON:0002810 | 41.88 | gold quality |
| ventricular zone | UBERON:0003053 | 41.07 | gold quality |
| hypothalamus | UBERON:0001898 | 41.00 | gold quality |
| brain | UBERON:0000955 | 40.19 | gold quality |
| right coronary artery | UBERON:0001625 | 38.65 | silver quality |
| bone marrow cell | CL:0002092 | 38.58 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 38.48 | gold quality |
| cerebral cortex | UBERON:0000956 | 38.37 | gold quality |
| frontal cortex | UBERON:0001870 | 38.30 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 36.43 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 36.18 | gold quality |
| prefrontal cortex | UBERON:0000451 | 35.92 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| muscle tissue | UBERON:0002385 | 34.81 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 34.71 | silver quality |
| duodenum | UBERON:0002114 | 34.61 | gold quality |
| tonsil | UBERON:0002372 | 34.15 | gold quality |
| substantia nigra | UBERON:0002038 | 33.99 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.79 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
24 targeting KRTAP5-11, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-10401-5P | 99.99 | 65.79 | 948 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-8082 | 99.95 | 67.27 | 1170 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-4496 | 99.88 | 68.89 | 2236 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-6764-5P | 99.75 | 67.89 | 2304 |
| HSA-MIR-1915-3P | 99.58 | 66.79 | 1988 |
| HSA-MIR-4784 | 99.15 | 67.41 | 1733 |
| HSA-MIR-6830-5P | 99.01 | 68.73 | 1884 |
| HSA-MIR-3150B-3P | 98.81 | 67.21 | 1728 |
| HSA-MIR-5011-3P | 98.63 | 64.81 | 638 |
| HSA-MIR-299-5P | 98.56 | 71.14 | 1140 |
| HSA-MIR-5187-5P | 98.54 | 67.94 | 952 |
| HSA-MIR-3664-3P | 97.85 | 67.62 | 1452 |
| HSA-MIR-7154-3P | 97.65 | 65.02 | 985 |
| HSA-MIR-493-3P | 97.50 | 66.44 | 731 |
| HSA-MIR-5685 | 97.02 | 64.34 | 1004 |
| HSA-MIR-1245A | 96.33 | 66.25 | 498 |
| HSA-MIR-8079 | 96.33 | 66.11 | 484 |
| HSA-MIR-139-3P | 95.24 | 63.10 | 316 |
| HSA-MIR-615-3P | 90.62 | 68.07 | 69 |
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Keratin-associated protein 5-11 — Q6L8G4 (reviewed: Q6L8G4)
Alternative names: Keratin-associated protein 5.11, Ultrahigh sulfur keratin-associated protein 5.11
All UniProt accessions (1): Q6L8G4
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated protein (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Tissue specificity. Restricted to hair root, not detected in any other tissues.
Similarity. Belongs to the KRTAP type 5 family.
RefSeq proteins (1): NP_001005405* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002494 | KAP | Family |
Pfam: PF13885
UniProt features (8 total): repeat 6, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6L8G4-F1 | 42.38 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 17 (showing top):
chr11q13, NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, ZWANG_EGF_INTERVAL_UP, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER, SNAPC4_TARGET_GENES, MIR153_5P, MIR299_5P, MIR4483, MIR5187_5P, MIR10401_5P, MIR1293
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): cytosol (GO:0005829), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
406 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP5-11 | KRTAP5-7 | Q6L8G8 | 715 |
| KRTAP5-11 | OR2G3 | Q8NGZ4 | 667 |
| KRTAP5-11 | OR13G1 | Q8NGZ3 | 607 |
| KRTAP5-11 | KRTAP4-3 | Q9BYR4 | 600 |
| KRTAP5-11 | OR6F1 | Q8NGZ6 | 576 |
| KRTAP5-11 | KRTAP4-1 | Q9BYQ7 | 574 |
| KRTAP5-11 | OR1C1 | Q15619 | 573 |
| KRTAP5-11 | OR2G2 | Q8NGZ5 | 528 |
| KRTAP5-11 | KRTAP6-1 | Q3LI64 | 528 |
| KRTAP5-11 | KRTAP19-8 | Q3LI54 | 506 |
| KRTAP5-11 | OR1N1 | Q8NGS0 | 505 |
| KRTAP5-11 | A0A3B3IRQ3 | A0A3B3IRQ3 | 505 |
| KRTAP5-11 | A8MUN0 | A8MUN0 | 480 |
| KRTAP5-11 | KRTAP22-1 | Q3MIV0 | 479 |
| KRTAP5-11 | KRTAP13-3 | Q3SY46 | 456 |
IntAct
187 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LCE1D | KRTAP5-11 | psi-mi:“MI:0915”(physical association) | 0.600 |
| LCE1E | KRTAP5-11 | psi-mi:“MI:0915”(physical association) | 0.600 |
| KRTAP5-11 | LCE1E | psi-mi:“MI:0915”(physical association) | 0.600 |
| CYSRT1 | KRTAP5-11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-11 | KRTAP2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-9 | KRTAP5-11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-11 | CRCT1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HOXA1 | KRTAP5-11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-11 | KRTAP5-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| POU4F2 | KRTAP5-11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-7 | KRTAP5-11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-11 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMCP | KRTAP5-11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RGS20 | KRTAP5-11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-11 | CATSPER1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP1-3 | KRTAP5-11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-11 | KRTAP9-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GLRX3 | KRTAP5-11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-6 | KRTAP5-11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OTX1 | KRTAP5-11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-11 | KRTAP9-8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE2C | KRTAP5-11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-11 | NR4A3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-8 | KRTAP5-11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE1B | KRTAP5-11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-9 | KRTAP5-11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE3B | KRTAP5-11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-11 | KRTAP4-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (65): KRTAP5-11 (Two-hybrid), KRTAP5-11 (Two-hybrid), KRTAP5-11 (Two-hybrid), KRTAP5-11 (Two-hybrid), KRTAP5-11 (Two-hybrid), KRTAP5-11 (Two-hybrid), KRTAP5-11 (Two-hybrid), KRTAP5-11 (Two-hybrid), KRTAP5-11 (Two-hybrid), KRTAP5-11 (Two-hybrid), KRTAP5-11 (Two-hybrid), KRTAP5-11 (Two-hybrid), KRTAP5-11 (Two-hybrid), KRTAP5-11 (Two-hybrid), KRTAP5-11 (Two-hybrid)
ESM2 similar proteins: A5A6P5, A6QP35, A8MTY7, A8MVA2, A8MXZ3, O75690, P02438, P02441, P02442, P02443, P08131, P0C7H8, P26371, P59990, P59991, P60014, P60331, P60368, P60369, P60370, P60371, P60372, P60409, P60410, P60411, P60412, P60413, Q05B44, Q07627, Q3V2C1, Q6L8G4, Q6L8G8, Q6L8G9, Q6L8H2, Q701N4, Q8IUG1, Q9BQ66, Q9BYP9, Q9BYQ0, Q9BYQ2
Diamond homologs: Q6L8G4, Q6L8G8
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 56 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 32 | 42.4× | 3e-47 |
| Formation of the cornified envelope | 14 | 29.3× | 8e-17 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| keratinization | 13 | 82.2× | 3e-20 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
51 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 48 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
1024 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:71582709:C:A | K43N | 0.709 |
| 11:71582709:C:G | K43N | 0.709 |
| 11:71582371:A:C | I156S | 0.706 |
| 11:71582373:C:A | K155N | 0.645 |
| 11:71582373:C:G | K155N | 0.645 |
| 11:71582403:G:C | S145R | 0.637 |
| 11:71582403:G:T | S145R | 0.637 |
| 11:71582405:T:G | S145R | 0.637 |
| 11:71582371:A:G | I156T | 0.633 |
| 11:71582725:G:T | P38H | 0.626 |
| 11:71582736:G:C | S34R | 0.580 |
| 11:71582736:G:T | S34R | 0.580 |
| 11:71582738:T:G | S34R | 0.580 |
| 11:71582478:G:C | S120R | 0.571 |
| 11:71582478:G:T | S120R | 0.571 |
| 11:71582480:T:G | S120R | 0.571 |
| 11:71582371:A:T | I156N | 0.569 |
| 11:71582385:G:C | C151W | 0.566 |
dbSNP variants (sampled 300 via entrez): RS1000959594 (11:71584619 G>A,T), RS1002154553 (11:71583731 T>G), RS1002826040 (11:71581652 C>A,T), RS1004155997 (11:71584265 C>G), RS1005229488 (11:71583559 C>T), RS1006643206 (11:71584499 T>C,G), RS1007499563 (11:71582088 C>A), RS1011442927 (11:71584544 C>T), RS1013022943 (11:71584649 G>C), RS1013461857 (11:71581793 T>G), RS1015527906 (11:71581819 G>A), RS1015580126 (11:71581661 C>G), RS1016439503 (11:71584577 C>T), RS1017278028 (11:71584278 G>A), RS1018554248 (11:71583388 T>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007000_5 | Logical memory (delayed recall) in mild cognitive impairment | 2.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004874 | memory performance |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 2 |
| Benzo(a)pyrene | affects methylation, increases methylation | 2 |
| Copper | affects cotreatment, decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.